Abstract
The description represents a clinical case of step-by-step surgical treatment of a patient with coronary heart
disease (three-vessel affection of coronary artery), 65—75% bicarotid stenosis of, and kidney cancer. Surgical
treatment in this case is determined by the need to reduce the risk of cardiovascular complications during
and after the surgical treatment of cancer. Myocardial revascularization has been performed — a two-stage
coronary stenting. Revascularization was performed in two areas — in the area of blood flow circumflex artery
and the left anterior descending artery. Due to the need for rapid cancellation of antiplatelet agents after
myocardial revascularization bare stents were preferred. As the third step stenting of the right carotid artery
was performed. However, appearance of the signs of clinical angina in three months after revascularization
required another coronary angiography. Significant «in stent» restenosis of anterior descending artery and
the obtuse marginal branch were identified, that required one more revascularization with drug-eluting
stents. Six months later a successful surgical treatment of cancer pathology was performed on the patient.
References
Lopez-Encuentra A. Bronchogenic Carcinoma Cooperative Group. Comorbidity in operable lung cancer. A multicenter descriptive study on 2992 patients. Lung Cancer. 2002; 35 (3): 263—9.
Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikofet E.L., Fleischmann K.E. et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2007; 116: e418—99.
Poldermans D., Bax J.J., Boersma E., De Hert S., Eeckhout E., Fowkes G. et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur. Heart J. 2009; 30 (22): 2769-812.
Babapulle M.N., Joseph L., Belisle P., Brophy J.M., Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet. 2004; 364 (9434): 583-91.
Dalton M., Parker M., Mistrol J., Bricker D. Concomitant coronary artery bypass and major non-cardiac surgery. J. Thorac. Cardiovasc. Surg. 1978; 75 (4): 621-4.
Brutel de la Riviere A., Knaepen P., Van Swieten H., Vanderschueren R., Ernst J., Van den Bosch J. Concomitant open heart surgery and pulmonary resection for lung cancer. Eur. J. Cardiothorac. Surg. 1995; 9 (6): 310-4.
Miller D.L., Orszulak T.A., Pairolero P.C., Trastek V.F., Schaff H.V. Combined operation for lung cancer and cardiac disease. Ann. Thorac. Surg. 1994; 58 (4): 989-93.
About the authors
Nikitina Tat'yana Georgievna, MD, DM, Professor, Chief of Department for cardiology of congenital heart diseases
Geletsyan Lilit Genrikovna, MD, PhD, Junior research associate
Dombrovskiy Mikhail Mikhaylovich, Postgraduate
Serguladze Tina Nodarovna, MD, PhD, Ultrasonic medical investigation specialist
Gerasimov Sergey Semenovich, MD, DM, Professor
Petrosyan Karen Valer'evich, MD, PhD, Endovascular surgeon
Alekyan Bagrat Gegamovich, Academician of Russian Academy of Sciences, Chief of Department of radiosurgical
methods of diagnosis and treatment of cardiovascular deseases
Bockeria Leo Antonovich, Academician of Russian Academy of Sciences and Russian Academy of Medical
Sciences, Director of A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences
